Series C · $62M · Oct 2026 · 1 open role
Biopharmaceutical company providing new payload mechanisms for antibody-drug conjugates (ADCs)
Startups that just raised and are hiring. Plus an AI job concierge that emails you when a role fits what you’re after. Free.